SE8903583D0 - CYCLOSPORIN OPHTHALMIC COMPOSITIONS - Google Patents

CYCLOSPORIN OPHTHALMIC COMPOSITIONS

Info

Publication number
SE8903583D0
SE8903583D0 SE8903583A SE8903583A SE8903583D0 SE 8903583 D0 SE8903583 D0 SE 8903583D0 SE 8903583 A SE8903583 A SE 8903583A SE 8903583 A SE8903583 A SE 8903583A SE 8903583 D0 SE8903583 D0 SE 8903583D0
Authority
SE
Sweden
Prior art keywords
ophthalmic compositions
compositions
cyclosporin
tissues
eye
Prior art date
Application number
SE8903583A
Other languages
Swedish (sv)
Other versions
SE8903583L (en
Inventor
R E Peeples
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8903583D0 publication Critical patent/SE8903583D0/en
Publication of SE8903583L publication Critical patent/SE8903583L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Abstract

Novel ophthalmic compositions comprising a cyclosporin, e.g. Ciclosporin, as active ingredient, and a vegetable oil, preferably cor oil, and a petroleum jelly, preferably white petrolatum, as carrier. The compositions are useful for topical ophthalmic application in the treatment of diseases or conditions affecting the eye, in particular interior structures or tissues of the eye, as well as of surrounding or associated organs or tissues.
SE8903583A 1988-10-26 1989-10-26 Ophthalmic cyclosporine compositions SE8903583L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26286688A 1988-10-26 1988-10-26

Publications (2)

Publication Number Publication Date
SE8903583D0 true SE8903583D0 (en) 1989-10-26
SE8903583L SE8903583L (en) 1990-04-27

Family

ID=22999400

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8903583A SE8903583L (en) 1988-10-26 1989-10-26 Ophthalmic cyclosporine compositions

Country Status (24)

Country Link
JP (1) JPH02164830A (en)
KR (1) KR900005973A (en)
AU (1) AU626928B2 (en)
BE (1) BE1003578A4 (en)
CA (1) CA2001502A1 (en)
CH (1) CH679210A5 (en)
DE (1) DE3935517A1 (en)
DK (1) DK531289A (en)
ES (1) ES2020032A6 (en)
FI (1) FI895064A0 (en)
FR (1) FR2638089A1 (en)
GB (1) GB2224205B (en)
GR (1) GR1000611B (en)
HU (1) HU203046B (en)
IL (1) IL92120A (en)
IT (1) IT1237824B (en)
LU (1) LU87613A1 (en)
MY (1) MY106271A (en)
NL (1) NL8902657A (en)
NO (1) NO894266L (en)
NZ (1) NZ231131A (en)
PT (1) PT92120B (en)
SE (1) SE8903583L (en)
ZA (1) ZA898140B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148748B1 (en) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 A multiphase cyclosporin composition
CA2002147A1 (en) * 1988-11-07 1990-05-07 Shuichi Morikawa Production process for polyimide fibers
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
FR2670629B1 (en) * 1990-12-17 1995-03-10 Moving Magnet Tech ROTARY SINGLE - PHASE ELECTROMAGNETIC ACTUATOR.
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
EP0642332B1 (en) 1992-05-13 1997-01-15 Sandoz Ltd. Ophthalmic compositions containing a cyclosporin
US5830508A (en) * 1992-08-06 1998-11-03 Deo Corporation Composition for treating dry eye
US5366739A (en) * 1992-08-06 1994-11-22 Deo Corporation Method of ophthalmic drug delivery
ES2168271T3 (en) 1992-09-25 2002-06-16 Novartis Ag PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORINS.
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
JP3833248B2 (en) 1994-11-03 2006-10-11 ノバルティス・アクチエンゲゼルシャフト Novel formulation of cyclosporine for oral administration with simple composition and high bioavailability and process for its production
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
KR20040004416A (en) 1997-01-30 2004-01-13 노파르티스 아게 Oil-Free Pharmaceutical Compositions Containing Cyclosporin A
US6254860B1 (en) * 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
US7557082B2 (en) 2006-03-03 2009-07-07 Allergan, Inc. Treatment with cyclosporin A
CN101848701A (en) * 2007-11-05 2010-09-29 博士伦公司 Water-immiscible materials as vehicles for drug delivery
MY172185A (en) * 2009-06-05 2019-11-15 Allergan Inc Artificial tears and therapeutic uses
MX2017006474A (en) 2014-11-25 2017-09-12 Allergan Inc Stabilized omega-3 ophthalmic compositions.
EP4201398A1 (en) * 2021-12-24 2023-06-28 Isoxa S.r.l. Isocyclosporin a for topical treatment of ocular diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin

Also Published As

Publication number Publication date
CA2001502A1 (en) 1990-04-26
DK531289D0 (en) 1989-10-25
MY106271A (en) 1995-04-29
GR1000611B (en) 1992-08-31
PT92120B (en) 1995-06-30
FR2638089A1 (en) 1990-04-27
NL8902657A (en) 1990-05-16
AU4371589A (en) 1990-05-03
HU895444D0 (en) 1990-01-28
IL92120A0 (en) 1990-07-12
ZA898140B (en) 1991-06-26
NO894266D0 (en) 1989-10-26
AU626928B2 (en) 1992-08-13
GR890100690A (en) 1990-11-29
PT92120A (en) 1990-04-30
GB8924040D0 (en) 1989-12-13
IL92120A (en) 1994-02-27
LU87613A1 (en) 1991-05-07
GB2224205A (en) 1990-05-02
BE1003578A4 (en) 1992-04-28
ES2020032A6 (en) 1991-07-16
CH679210A5 (en) 1992-01-15
JPH02164830A (en) 1990-06-25
FI895064A0 (en) 1989-10-25
KR900005973A (en) 1990-05-07
NO894266L (en) 1990-04-27
IT8948485A0 (en) 1989-10-26
SE8903583L (en) 1990-04-27
DE3935517A1 (en) 1990-05-03
HUT52394A (en) 1990-07-28
NZ231131A (en) 1992-06-25
IT1237824B (en) 1993-06-18
HU203046B (en) 1991-05-28
GB2224205B (en) 1992-04-15
DK531289A (en) 1990-04-27

Similar Documents

Publication Publication Date Title
SE8903583D0 (en) CYCLOSPORIN OPHTHALMIC COMPOSITIONS
MX9702349A (en) Use of 9-deoxy prostaglandin derivatives to treat glaucoma.
ATE134477T1 (en) BIOCIDAL COMPOSITIONS
WO2003051294A3 (en) Mitocidal compositions and methods
ATE296612T1 (en) ACTIVE INGREDIENTS FOR THE TREATMENT OF SENIL XEROSIS AND PREPARATIONS
DE69617723T2 (en) GEL FORMULAS CONTAINING GROWTH FACTORS
LV10180A (en) Pharmaceutical composition
BR0209709A (en) Hypotensive lipid and timolol compositions and methods of use thereof
ATE211135T1 (en) AMINOCYCLOHEXYL ESTER AND THEIR APPLICATION
DE69713151D1 (en) CYCLOSPORINE DERIVATIVE, THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITION
DE69030476D1 (en) Use of protease inhibitors as anti-exudative, anti-inflammatory and anti-microbial agents
GEP20002332B (en) Cefalosporin Derivatives
ATE319458T1 (en) MEDICAL COMPOSITIONS FOR TREATING EYE DISEASES
DK284386D0 (en) PHARMACEUTICAL PREPARATION FOR SKIN DISORDERS
ATE223200T1 (en) EYE MEDICINAL CONTAINING A CARBOANHYDRASE INHIBITOR AND XANTHANG GUM
ATE216889T1 (en) USE OF PROSTAGRANDIN ANALOGUE FOR THE TREATMENT OF GLAUCOMA AND OCCULAR HYPERTENSION
FR2753371B1 (en) USE OF AN EXTRACT FROM THE TERMINALIA CATAPPA PLANT AND DERMATOLOGICAL AND PHARMACEUTICAL COSMETIC COMPOSITIONS COMPRISING SUCH EXTRACT
DE69728536D1 (en) PREPARATIONS CONTAINS A NITRONE COMPOUND FOR USE IN THE TREATMENT OF UVEITIS
EP0373771A3 (en) New pharmaceutical uses for cystatins
ES2063440T3 (en) USE OF POLYSACCHARIDES IN PREPARATIONS FOR WOUND TREATMENT.
ES2153584T3 (en) PIRIDINIMINIL-1,2-BENZISOXAZOL AND -BENZISOTIAZOL AS ANTIPSYCHOTICS.
ES2162022T3 (en) TIOL DERIVATIVES WITH INHIBITING ACTIVITY OF METALOPEPTIDASA.
AU5448490A (en) Compositions and processes for improving the cosmetic appearance, growths or healing characteristics of tissue
FR2779844B1 (en) INTERCONNECTION STRUCTURE BETWEEN ADDRESSABLE ORGANS OF A MICROCALCULATOR, IN PARTICULAR FOR AN IMPLANTABLE ACTIVE MEDICAL DEVICE SUCH AS A CARDIAC STIMULATOR OR DEFIBRILLATOR
ATE204169T1 (en) INTRAOCULAR IRRIGATION SOLUTION CONTAINING POLYAMINE ANTAGONISTS

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8903583-6